| Product NDC: | 65483-093 |
| Proprietary Name: | RIDAURA |
| Non Proprietary Name: | auranofin |
| Active Ingredient(s): | 3 mg/1 & nbsp; auranofin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65483-093 |
| Labeler Name: | Prometheus Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018689 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19850424 |
| Package NDC: | 65483-093-06 |
| Package Description: | 60 CAPSULE in 1 BOTTLE (65483-093-06) |
| NDC Code | 65483-093-06 |
| Proprietary Name | RIDAURA |
| Package Description | 60 CAPSULE in 1 BOTTLE (65483-093-06) |
| Product NDC | 65483-093 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | auranofin |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19850424 |
| Marketing Category Name | NDA |
| Labeler Name | Prometheus Laboratories Inc. |
| Substance Name | AURANOFIN |
| Strength Number | 3 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |